Cheryl Arrowsmith

From Wikipedia, the free encyclopedia

Cheryl Arrowsmith is a noted Toronto-based structural biologist and the Chief Scientist at the Toronto lab of the Structural Genomics Consortium. Her contributions to protein structural biology includes the use of NMR and X-ray crystallography.

Dr. Arrowsmith received her PhD in chemistry at the University of Toronto and post-doctoral training at Stanford University. One of her areas of interest is the tumour suppresor p53 and related proteins.

Dr. Arrowsmith was a co-founder of Toronto-based biotech company Affinium Pharmaceuticals.

[edit] External links

  • [1] homepage.
  • [2] UHN profile
  • [3] Faculty of 1000 profile
Darwin This article about a biologist is a stub. You can help Wikipedia by expanding it.


This article about a Canadian scientist is a stub. You can help Wikipedia by expanding it.
Retrieved from "http://en.wikipedia.org../../../c/h/e/Cheryl_Arrowsmith_6009.html"